Trials / Sponsors / Bellerophon Pulse Technologies

Bellerophon Pulse Technologies

Industry · 7 registered clinical trials.

Status	Trial	Phase	Started
Terminated	A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypert Pulmonary Fibrosis, Pulmonary Hypertension	Phase 3	2020-12-14
Terminated	A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19 COVID-19, Coronavirus, Coronavirus Infection	Phase 3	2020-07-12
Withdrawn	Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Pulmonary Arterial Hypertension	Phase 3	2018-08-01
Terminated	Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH Pulmonary Arterial Hypertension	Phase 3	2016-04-01
Unknown	Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH Pulmonary Arterial Hypertension	Phase 3	2016-03-01
Completed	Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertens Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease	Phase 2	2012-12-01
Completed	Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH) Pulmonary Arterial Hypertension, Pulmonary Hypertension	Phase 2	2012-04-01